Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP964046.RA6S9XBKsXeMZX_ujZciWDiWfhJQQX1MaimEHPJEv4ti4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP964046.RA6S9XBKsXeMZX_ujZciWDiWfhJQQX1MaimEHPJEv4ti4130_assertion type Assertion NP964046.RA6S9XBKsXeMZX_ujZciWDiWfhJQQX1MaimEHPJEv4ti4130_head.
- NP964046.RA6S9XBKsXeMZX_ujZciWDiWfhJQQX1MaimEHPJEv4ti4130_assertion description "[Furthermore, MECOM mRNA and protein expression were repressed by imatinib mesylate treatment of CML-CP CD34(+) cells, K562 and KY01 cell lines whereas imatinib had no effect in non-CML BCR-ABL1 -ve CD34(+) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP964046.RA6S9XBKsXeMZX_ujZciWDiWfhJQQX1MaimEHPJEv4ti4130_provenance.
- NP964046.RA6S9XBKsXeMZX_ujZciWDiWfhJQQX1MaimEHPJEv4ti4130_assertion evidence source_evidence_literature NP964046.RA6S9XBKsXeMZX_ujZciWDiWfhJQQX1MaimEHPJEv4ti4130_provenance.
- NP964046.RA6S9XBKsXeMZX_ujZciWDiWfhJQQX1MaimEHPJEv4ti4130_assertion SIO_000772 22372463 NP964046.RA6S9XBKsXeMZX_ujZciWDiWfhJQQX1MaimEHPJEv4ti4130_provenance.
- NP964046.RA6S9XBKsXeMZX_ujZciWDiWfhJQQX1MaimEHPJEv4ti4130_assertion wasDerivedFrom befree-2016 NP964046.RA6S9XBKsXeMZX_ujZciWDiWfhJQQX1MaimEHPJEv4ti4130_provenance.
- NP964046.RA6S9XBKsXeMZX_ujZciWDiWfhJQQX1MaimEHPJEv4ti4130_assertion wasGeneratedBy ECO_0000203 NP964046.RA6S9XBKsXeMZX_ujZciWDiWfhJQQX1MaimEHPJEv4ti4130_provenance.